News

Harbour BioMed (HBM) and Viva Biotech (Shanghai) Ltd. announced a strategic partnership under which both parties will collate their respective expertise in drug discovery and…
Read More...

UCB announced an agreement to enter into a world-wide, exclusive license agreement with Roche and Genentech, a member of the Roche Group, for the global development and…
Read More...

Intravacc, a global leader in translational research and development of viral and bacterial vaccines, and Celonic Group, a premium biopharmaceutical contract development and…
Read More...

Piramal Pharma Solutions announced that it is providing Bolt Biotherapeutics (Bolt) with the supply of both the BDC-1001 ISAC drug substance and the drug product for Bolt's ongoing…
Read More...

At the direction of President Donald J. Trump, U.S. International Development Finance Corporation (DFC) Chief Executive Officer Adam Boehler will today sign a letter of interest (LOI)…
Read More...

Karuna Therapeutics, Inc. an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with…
Read More...

Viva Biotech Holdings and Schrödinger, Inc. announced a strategic collaboration to expand the reach of structure-based drug discovery by generating de novo crystal structures of…
Read More...

NeoImmuneTech, Inc., a clinical-stage T cell-focused biopharmaceutical company, announced receipt of IND clearance from the US Federal Drug Administration (FDA) to evaluate NT-I7…
Read More...

Zentalis Pharmaceuticals, Inc. announced a clinical collaboration agreement with Eli Lilly and Company in which Zentalis will evaluate the combination of ZN-c5, the Company’s oral…
Read More...

Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, and Cyclica, whose AI-augmented, integrated platform enables…
Read More...

AstraZeneca has entered into a new global development and commercialisation agreement with Daiichi Sankyo Company, Limited (Daiichi Sankyo) for DS-1062, Daiichi Sankyo’s proprietary…
Read More...

Emergent BioSolutions Inc. announced that it has signed an agreement to provide contract development and manufacturing (CDMO) services for large-scale commercial drug substance…
Read More...

Sandoz announced the plans for a joint investment, together with the Austrian federal government, to strengthen the long-term future of integrated antibiotics manufacturing in Europe.…
Read More...

Moderna, Inc. announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against COVID-19 has begun dosing participants. The Phase 3 study, called the COVE (Coronavirus…
Read More...

Pfizer Inc. and BioNTech SE announced the execution of an agreement with the U.S. Department of Health and Human Services and the Department of Defense to meet the U.S. government’s…
Read More...

Dynavax Technologies Corporation and Medigen Vaccine Biologics Corporation announced their collaboration to develop an adjuvanted vaccine candidate to protect against COVID-19. The…
Read More...

Grifols announced it has acquired 10% of Bloodbuy (BloodSolutions, LLC), a cloud-based marketplace that facilitates buying and selling of blood components in the U.S. Bloodbuy's…
Read More...

Arcturus Therapeutics Holdings Inc. announced a binding term sheet with the Israeli Ministry of Health to supply the Company’s COVID-19 vaccine candidate, LUNAR-COV19. The parties…
Read More...

Astellas Venture Management LLC, a wholly-owned venture capital subsidiary of Astellas Pharma Inc., and LabCentral, a launchpad for early-stage life-sciences startups, today announced…
Read More...

Synaffix B.V., a biotechnology company focused on enabling antibody-drug conjugates (ADCs) with superior therapeutic index based on its proprietary ADC technology platform, announces…
Read More...